追蹤
Kimberly Powers
Kimberly Powers
Assistant Professor of Epidemiology, University of North Carolina at Chapel Hill
在 email.unc.edu 的電子郵件地址已通過驗證
標題
引用次數
引用次數
年份
Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis
KA Powers, C Poole, AE Pettifor, MS Cohen
The Lancet infectious diseases 8 (9), 553-563, 2008
4842008
Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection
CD Pilcher, G Joaki, IF Hoffman, FEA Martinson, C Mapanje, PW Stewart, ...
Aids 21 (13), 1723-1730, 2007
3832007
The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study
KA Powers, AC Ghani, WC Miller, IF Hoffman, AE Pettifor, G Kamanga, ...
The Lancet 378 (9787), 256-268, 2011
3542011
Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here?
MS Cohen, MK Smith, KE Muessig, TB Hallett, KA Powers, AD Kashuba
The Lancet 382 (9903), 1515-1524, 2013
3152013
Role of acute and early HIV infection in the sexual transmission of HIV
WC Miller, NE Rosenberg, SE Rutstein, KA Powers
Current Opinion in HIV and AIDS 5 (4), 277-282, 2010
2692010
The year-long effect of HIV-positive test results on pregnancy intentions, contraceptive use, and pregnancy incidence among Malawian women
IF Hoffman, FEA Martinson, KA Powers, DA Chilongozi, ED Msiska, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 47 (4), 477-483, 2008
1652008
Community viral load as a measure for assessment of HIV treatment as prevention
WC Miller, KA Powers, MK Smith, MS Cohen
The Lancet infectious diseases 13 (5), 459-464, 2013
1492013
HIV treatment as prevention: debate and commentary—will early infection compromise treatment-as-prevention strategies?
MS Cohen, C Dye, C Fraser, WC Miller, KA Powers, BG Williams
PLoS medicine 9 (7), e1001232, 2012
1362012
Antiviral agents and HIV prevention: controversies, conflicts, and consensus
MS Cohen, KE Muessig, MK Smith, KA Powers, ADM Kashuba
Aids 26 (13), 1585-1598, 2012
1262012
Improved detection of acute HIV-1 infection in sub-Saharan Africa: development of a risk score algorithm
KA Powers, WC Miller, CD Pilcher, C Mapanje, FEA Martinson, SA Fiscus, ...
Aids 21 (16), 2237-2242, 2007
1242007
Rapid, real-time detection of acute HIV infection in patients in Africa
SA Fiscus, CD Pilcher, WC Miller, KA Powers, IF Hoffman, M Price, ...
The Journal of infectious diseases 195 (3), 416-424, 2007
1242007
HIV-1 treatment as prevention: the good, the bad, and the challenges
K Smith, KA Powers, ADM Kashuba, MS Cohen
Current Opinion in HIV and AIDS 6 (4), 315-325, 2011
1212011
Kinetics of hepatitis C virus reinfection after liver transplantation
KA Powers, RM Ribeiro, K Patel, S Pianko, L Nyberg, P Pockros, ...
Liver Transplantation 12 (2), 207-216, 2006
1002006
Pharmacodynamics of PEG‐IFN α differentiate HIV/HCV coinfected sustained virological responders from nonresponders
AH Talal, RM Ribeiro, KA Powers, M Grace, C Cullen, M Hussain, ...
Hepatology 43 (5), 943-953, 2006
982006
Incident HIV among pregnant and breast-feeding women in sub-Saharan Africa: a systematic review and meta-analysis
LA Graybill, M Kasaro, K Freeborn, JS Walker, C Poole, KA Powers, ...
Aids 34 (5), 761-776, 2020
912020
HIV treatment as prevention: the utility and limitations of ecological observation
MK Smith, KA Powers, KE Muessig, WC Miller, MS Cohen
PLoS medicine 9 (7), e1001260, 2012
902012
Does ART prevent HIV transmission among MSM?
KE Muessig, MK Smith, KA Powers, YR Lo, DN Burns, AE Grulich, ...
Aids 26 (18), 2267-2273, 2012
882012
Dynamics of alanine aminotransferase during hepatitis C virus treatment
RM Ribeiro, J Layden-Almer, KA Powers, TJ Layden, AS Perelson
Hepatology 38 (2), 509-517, 2003
872003
The detection and management of early HIV infection: a clinical and public health emergency
MK Smith, SE Rutstein, KA Powers, S Fidler, WC Miller, JJ Eron Jr, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 63, S187-S199, 2013
842013
Modeling viral and drug kinetics: hepatitis C virus treatment with pegylated interferon alfa-2b
KA Powers, NM Dixit, RM Ribeiro, P Golia, AH Talal, AS Perelson
Seminars in liver disease 23 (S 1), 013-018, 2003
712003
系統目前無法執行作業,請稍後再試。
文章 1–20